Loading...
NPI 1528089570 · Delta, UT · Community/Retail Pharmacy
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Service Drug Company Inc is a community/retail pharmacy provider located in Delta, Utah. This profile covers 8 Medicare and 4 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Service Drug Company Inc |
| Address | 215 W Main St |
| City | Delta |
| State | UT |
| ZIP | 84624 |
| Taxonomy | Community/Retail Pharmacy |
| NPI Enumerated | July 22, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $55.3K |
| Medicaid | $5.1K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
8 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 90694 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is an inactivated, adjuvanted, preservative–free vaccine given as a 0.5 mL… | 270 | $80 | $20.4K |
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 80 | $140 | $10.7K |
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 70 | $130 | $9.2K |
| G0008 | Administration of influenza virus vaccine | 280 | $30 | $8.1K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 150 | $40 | $5.7K |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 40 | $10 | $370 |
| G0009 | Administration of pneumococcal vaccine | 10 | $30 | $320 |
| 90688 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It uses split virus technology and is given as a 0.5 mL dose. | 10 | $20 | $240 |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 8 CPT/HCPCS codes.
View: State1 / 2
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
4 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| E0570 | Nebulizer, with compressor | 460 | $10 | $4.1K |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 20 | $50 | $1.1K |
| 90694 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is an inactivated, adjuvanted, preservative–free vaccine given as a 0.5 mL… | 20 | $0 | $0 |
| G0008 | Administration of influenza virus vaccine | 20 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Utah providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Utah median
4 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 63 | 70 | 340 | $50 | $117.7K |
| E0570 | Nebulizer, with compressor | 13 | 30 | 450 | $10 | $24K |
| G0008 | Administration of influenza virus vaccine | 43 | 50 | 40 | $1 | $2.1K |
| 90694 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is an inactivated, adjuvanted, preservative–free vaccine given as a 0.5 mL… | 6 | 10 | 20 | $1 | $240 |
Other providers in the same ZIP code as Service Drug Company Inc, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Ihc Health Services, Inc. | UT | Critical Access Hospital | $0 | $524.8K |
| Ihc Health Services Inc | UT | Family Medicine Physician | $0 | $305.7K |
| Alan Smith | UT | Family Medicine Physician | $286.7K | $0 |
| Randy Stinson | UT | Physical Therapist | $238.5K | $0 |
| Steven Shamo | UT | Family Medicine Physician | $94.8K | $0 |
| Spencer Nielson | UT | Family Medicine Physician | $65.7K | $0 |
| Mandy Lemmon | UT | Family Nurse Practitioner | $22.8K | $0 |
| Katy Roper | UT | Speech-Language Pathologist | $11.9K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.